Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 823 results for "merck co"

BRIEF-Merck CEO says importing drugs from outside U.S. not ...

Merck CEO Says Drugmaker Is Restrained on Price Increases

Merck & Co. CEO Kenneth Frazier stressed that his company has been disciplined regarding price increases on its products, Bloomberg reported. "There will always be an individual drug in an individual year that you can point to and say, 'That ... FirstWord Pharma, 21 hours ago

194 images for merck co

Mideast Time, 22 hours ago
American Banking News, 4 days ago
American Banking News, 1 week ago
Mideast Time, 2 weeks ago
Yahoo! Finance, 1 day ago, 2 days ago
Nasdaq, 2 days ago
Yahoo! Finance, 1 week ago
Post Online Media, 2 weeks ago
Yahoo! Finance, 1 week ago

Aetna Puts New Stamp on Diabetes With Merck Outcomes-Based Deal

Aetna Inc. on Oct. 11 unveiled a new pact with Merck & Co. for that drug maker's Januvia and Janumet Type 2 diabetes drugs that will further outcomes-based contracting for prescription drugs on the insurer's preferred formulary list. The deal ...
 AISHealth.com23 hours ago Merck's New Drugs, Cost Management to Fuel Growth in 2017  Yahoo! Singapore1 week ago Couple Accuses Merck & Co. of Failing to Disclose Zostavax Vaccine Side Effects  BioSpace2 weeks ago
Yahoo! Finance

Merck & Co., Inc. (MRK) Gets Coveted Approval For Keytruda

Individual lung cancer patients may soonbe able to benefit from Keytruda, an immunotherapy drug from Merck & Co., Inc. (NYSE: MRK ) . The news comes after the confirmation by the New Jersey drug maker that it had gained a second priority review tag ...
 InsiderMonkey.com1 day ago Merck & Co., Inc (NYSE:MRK) Gets Coveted Approval For Keytruda  4 Traders1 day ago NICE recommends Merck & Co.'s Keytruda for lung cancer following further price discount  FirstWord Pharma1 day ago MERCK : New KEYTRUDA┬« (pembrolizumab) Data to be Presented at 17th World Conference on Lung Cancer Highlight Research Across the Spectrum of Thoracic Malignancies  4 Traders3 days ago
Huffington Post Black Voices

Pharma execs weigh in on possible changes under Trump

(Recasts to add comments from Merck CEO on drug imports) By Ransdell Pierson Dec 1 (Reuters) - The top executives at two of the largest U.S. drugmakers weighed in on Thursday for the first time on possible changes for the industry next year under ...
 Yahoo! Finance1 day ago How The Trump Administration Could Hurt The Pharmaceutical Industry  Huffington Post Black Voices1 day ago Pharma executives weigh in on possible changes under Trump  Reuters UK1 day ago UPDATE 2-Pharma execs weigh in on possible changes under Trump  Reuters UK1 day ago

US FDA accepts EMD Serono's BLA for avelumab to treat metastatic MCC for priority review

EMD Serono Inc., the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has accepted for Priority Review EMD Serono's Biologics License ...
 PharmaBiz2 days ago FDA accepts avelumab BLA under Priority Review for rare type of skin cancer  Seeking Alpha4 days ago Merck : FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review  4 Traders4 days ago BRIEF-FDA grants priority review to Merck's application to expand use of Keytruda in hodgkin lymphoma  Reuters UK2 days ago
Yahoo! Finance

Merck & Co., Inc. breached its 50 day moving average in a Bearish Manner : MRK-US : December 1, 2016

More Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day's closing price. Technical Indicators Below is a quick look at 5 technical indicators for Merck & Co., Inc.. More studies are available ...
 Yahoo! Finance2 days ago

Natrix Separations announces collaboration agreements with Merck and Sanofi for the development of membrane-based Protein A purification platform

BURLINGTON, Ontario , Nov. 30, 2016 /CNW/ --Natrix Separations Inc. today announced development agreements with Merck, known as MSD outside the United States and Canada , and Sanofi to advance Natrix's new membrane-based Protein A platform for ...
 Canada NewsWire3 days ago Evotec AG And Merck & Co. Enter Into Agreements To Collaborate On Target Discovery Technologies  BioSpace2 days ago BRIEF-Natrix Separations announces collaboration agreements with Merck and Sanofi  Reuters UK3 days ago Natrix Separations, Inc. Announces Collaboration Agreements With Merck & Co. And Sanofi For The Development Of Membrane-Based Protein A Purification Platform  BioSpace3 days ago

Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab

Pfizer, Inc. PFE and German partner Merck KGaA MKGAF announced that the Biologics License Application (sBLA) for their experimental anti-PD-L1 monoclonal antibody, avelumab, has been accepted for priority review by the FDA. Pfizer shares rose 0.7% ...
 Yahoo! Finance3 days ago
Reuters India

German Merck, Pfizer get FDA priority review for cancer drug

FRANKFURT, Nov 29 (Reuters) - German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek approval to fight a rare and aggressive form of skin cancer with immunotherapy drug ...
 Yahoo! Finance4 days ago

Better Buy: Celgene Corporation vs. Merck & Co.

Over the past month, Celgene ( NASDAQ:CELG ) shares notched a gain of more than 20%, while Merck & Co. ( NYSE:MRK ) stock has risen about 17% year to date. Both drugmakers have exciting futures in the oncology space. With worldwide cancer medicine ...
 Motley Fool1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less